| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.985 | 0.001 | 0.985 | Androgen antagonist | 0.654 0.003 DBMET02481 0.902 0.002 DBMET02482 0.965 0.001 DBMET02483 0.969 0.001 DBMET02484 0.969 0.001 DBMET02485 0.733 0.003 DBMET03697 | ||
| 0.982 | 0.001 | 0.982 | Diuretic | 0.892 0.002 DBMET02481 0.882 0.002 DBMET02482 0.944 0.001 DBMET02483 0.896 0.002 DBMET02484 0.896 0.002 DBMET02485 0.835 0.002 DBMET03697 | ||
| 0.975 | 0 | 0.975 | Aldosterone antagonist | 0.739 0.001 DBMET02481 0.803 0.001 DBMET02482 0.947 0 DBMET02483 0.79 0.001 DBMET02484 0.79 0.001 DBMET02485 0.781 0.001 DBMET03697 | ||
| 0.916 | 0.001 | 0.916 | Aromatase inhibitor | 0.8 0.002 DBMET02481 0.669 0.002 DBMET02482 0.785 0.002 DBMET02483 0.745 0.002 DBMET02484 0.745 0.002 DBMET02485 0.621 0.003 DBMET03697 | ||
| 0.897 | 0.006 | 0.897 | Transcription factor NF kappa B inhibitor | 0.699 0.02 DBMET02481 0.715 0.019 DBMET02482 0.817 0.012 DBMET02483 0.869 0.008 DBMET02484 0.869 0.008 DBMET02485 0.696 0.021 DBMET03697 | ||
| 0.876 | 0.001 | 0.876 | Mineralocorticoid receptor antagonist | 0.78 0.001 DBMET02481 0.762 0.001 DBMET02482 0.854 0.001 DBMET02483 0.822 0.001 DBMET02484 0.822 0.001 DBMET02485 0.7 0.002 DBMET03697 | ||
| 0.876 | 0.004 | 0.876 | Cardiotonic | 0.706 0.005 DBMET02481 0.433 0.023 DBMET02482 0.737 0.005 DBMET02483 0.752 0.005 DBMET02484 0.752 0.005 DBMET02485 0.411 0.027 DBMET03697 | ||
| 0.849 | 0.001 | 0.849 | Progesterone antagonist | 0.659 0.002 DBMET02481 0.805 0.001 DBMET02482 0.763 0.001 DBMET02483 0.694 0.002 DBMET02484 0.694 0.002 DBMET02485 0.469 0.002 DBMET03697 | ||
| 0.817 | 0.001 | 0.817 | Androgen agonist | 0.338 0.003 DBMET02481 0.527 0.002 DBMET02482 0.514 0.002 DBMET02483 0.674 0.001 DBMET02484 0.674 0.001 DBMET02485 0.359 0.003 DBMET03697 | ||
| 0.713 | 0.004 | 0.713 | P-glycoprotein inhibitor | 0.518 0.007 DBMET02481 0.369 0.019 DBMET02482 0.633 0.004 DBMET02483 0.622 0.005 DBMET02484 0.622 0.005 DBMET02485 0.405 0.016 DBMET03697 | ||
| 0.676 | 0.003 | 0.676 | Estrogen receptor alpha antagonist | 0.213 0.008 DBMET02481 0.166 0.01 DBMET02482 0.366 0.004 DBMET02483 0.221 0.007 DBMET02484 0.221 0.007 DBMET02485 0.409 0.004 DBMET03697 | ||
| 0.673 | 0.001 | 0.811 | Lipocortins synthesis antagonist | 0.696 0.001 DBMET02481 0.811 0.001 DBMET02482 0.687 0.001 DBMET02483 0.634 0.002 DBMET02484 0.634 0.002 DBMET02485 0.644 0.002 DBMET03697 | DBMET02482 | |
| 0.67 | 0.005 | 0.67 | Vasodilator | 0.218 0.091 DBMET02482 0.167 0.134 DBMET02483 0.218 0.091 DBMET02484 0.218 0.091 DBMET02485 0.188 0.114 DBMET03697 | ||
| 0.599 | 0.016 | 0.599 | Antithrombotic | 0.359 0.061 DBMET02481 0.203 0.173 DBMET02482 0.367 0.059 DBMET02483 0.511 0.028 DBMET02484 0.511 0.028 DBMET02485 0.27 0.111 DBMET03697 | ||
| 0.575 | 0.004 | 0.841 | Estrogen antagonist | 0.371 0.005 DBMET02481 0.284 0.007 DBMET02482 0.511 0.004 DBMET02483 0.429 0.004 DBMET02484 0.429 0.004 DBMET02485 0.841 0.002 DBMET03697 | DBMET03697 | |
| 0.569 | 0.003 | 0.849 | Estrogen agonist | 0.392 0.004 DBMET02481 0.236 0.007 DBMET02482 0.488 0.004 DBMET02483 0.429 0.004 DBMET02484 0.429 0.004 DBMET02485 0.849 0.002 DBMET03697 | DBMET03697 | |
| 0.547 | 0.002 | 0.547 | Estrogen receptor beta agonist | 0.294 0.004 DBMET02481 0.202 0.005 DBMET02482 0.437 0.003 DBMET02483 0.343 0.004 DBMET02484 0.343 0.004 DBMET02485 0.196 0.005 DBMET03697 | ||
| 0.506 | 0.031 | 0.549 | Immunosuppressant | 0.399 0.063 DBMET02481 0.549 0.021 DBMET02482 0.459 0.044 DBMET02483 0.51 0.03 DBMET02484 0.51 0.03 DBMET02485 0.479 0.039 DBMET03697 | DBMET02482 | |
| 0.473 | 0.002 | 0.646 | Estradiol 17 beta-dehydrogenase inhibitor | 0.469 0.002 DBMET02481 0.499 0.002 DBMET02482 0.646 0.002 DBMET02483 0.47 0.002 DBMET02484 0.47 0.002 DBMET02485 0.468 0.002 DBMET03697 | DBMET02483 | |
| 0.462 | 0.018 | 0.462 | Tumour necrosis factor alpha release inhibitor | 0.28 0.062 DBMET02482 0.179 0.127 DBMET02484 0.179 0.127 DBMET02485 | ||
| 0.494 | 0.076 | 0.742 | Apoptosis agonist | 0.474 0.082 DBMET02481 0.742 0.024 DBMET02482 0.509 0.072 DBMET02483 0.556 0.059 DBMET02484 0.556 0.059 DBMET02485 0.466 0.085 DBMET03697 | DBMET02482 | |
| 0.416 | 0.013 | 0.456 | Sodium/bile acid cotransporter inhibitor | 0.425 0.011 DBMET02481 0.456 0.007 DBMET02482 0.434 0.009 DBMET02483 0.427 0.011 DBMET02484 0.427 0.011 DBMET02485 0.442 0.009 DBMET03697 | DBMET02482 | |
| 0.366 | 0.005 | 0.627 | Hedgehog signaling inhibitor | 0.475 0.004 DBMET02481 0.627 0.004 DBMET02482 0.597 0.004 DBMET02483 0.433 0.004 DBMET02484 0.433 0.004 DBMET02485 0.346 0.005 DBMET03697 | DBMET02482 | |
| 0.326 | 0.002 | 0.326 | Glucocorticoid antagonist | 0.251 0.003 DBMET02481 0.25 0.003 DBMET02482 0.317 0.003 DBMET02483 0.216 0.003 DBMET02484 0.216 0.003 DBMET02485 0.164 0.004 DBMET03697 | ||
| 0.302 | 0.003 | 0.808 | Estrogen receptor alpha agonist | 0.343 0.003 DBMET02481 0.098 0.009 DBMET02482 0.332 0.003 DBMET02483 0.284 0.004 DBMET02484 0.284 0.004 DBMET02485 0.808 0.001 DBMET03697 | DBMET03697 | |
| 0.3 | 0.005 | 0.814 | Estrogen receptor beta antagonist | 0.246 0.007 DBMET02481 0.133 0.021 DBMET02482 0.356 0.005 DBMET02483 0.243 0.007 DBMET02484 0.243 0.007 DBMET02485 0.814 0.002 DBMET03697 | DBMET03697 | |
| 0.288 | 0.004 | 0.288 | Potassium channel Kv1.5 blocker | 0.157 0.007 DBMET02483 0.143 0.008 DBMET02484 0.143 0.008 DBMET02485 | ||
| 0.32 | 0.037 | 0.428 | Nitric oxide antagonist | 0.328 0.035 DBMET02481 0.428 0.022 DBMET02482 0.332 0.035 DBMET02483 0.381 0.028 DBMET02484 0.381 0.028 DBMET02485 0.373 0.029 DBMET03697 | DBMET02482 | |
| 0.295 | 0.015 | 0.295 | Interleukin 6 antagonist | 0.195 0.044 DBMET02481 0.25 0.023 DBMET02482 0.266 0.02 DBMET02483 0.266 0.02 DBMET02484 0.266 0.02 DBMET02485 0.261 0.021 DBMET03697 | ||
| 0.381 | 0.102 | 0.601 | Cyclophilin D inhibitor | 0.54 0.04 DBMET02483 0.601 0.027 DBMET02484 0.601 0.027 DBMET02485 0.44 0.071 DBMET03697 | DBMET02485 | |
| 0.275 | 0.003 | 0.285 | Arachidonic acid antagonist | 0.259 0.004 DBMET02481 0.283 0.003 DBMET02482 0.275 0.003 DBMET02483 0.262 0.004 DBMET02484 0.262 0.004 DBMET02485 0.285 0.002 DBMET03697 | DBMET03697 | |
| 0.301 | 0.073 | 0.333 | Interleukin 2 agonist | 0.312 0.066 DBMET02481 0.32 0.061 DBMET02482 0.309 0.068 DBMET02483 0.333 0.054 DBMET02484 0.333 0.054 DBMET02485 0.294 0.078 DBMET03697 | DBMET02485 | |
| 0.227 | 0.003 | 0.252 | RNA-directed RNA polymerase stimulant | 0.252 0.002 DBMET02481 0.247 0.002 DBMET02482 0.246 0.002 DBMET02483 0.191 0.003 DBMET02484 0.191 0.003 DBMET02485 0.196 0.003 DBMET03697 | DBMET02481 | |
| 0.22 | 0.035 | 0.417 | Interferon gamma antagonist | 0.262 0.026 DBMET02481 0.417 0.01 DBMET02482 0.274 0.024 DBMET02483 0.241 0.03 DBMET02484 0.241 0.03 DBMET02485 0.302 0.02 DBMET03697 | DBMET02482 | |
| 0.208 | 0.025 | 0.374 | Cholesterol synthesis inhibitor | 0.243 0.019 DBMET02481 0.359 0.006 DBMET02482 0.228 0.021 DBMET02483 0.374 0.005 DBMET02484 0.374 0.005 DBMET02485 0.26 0.016 DBMET03697 | DBMET02485 | |
| 0.182 | 0.005 | 0.447 | 5-Alpha-reductase inhibitor | 0.229 0.004 DBMET02481 0.447 0.002 DBMET02482 0.216 0.004 DBMET02483 0.196 0.005 DBMET02484 0.196 0.005 DBMET02485 0.168 0.006 DBMET03697 | DBMET02482 | |
| 0.177 | 0.011 | 0.177 | Analgesic, opioid | |||
| 0.17 | 0.004 | 0.212 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.108 0.005 DBMET02481 0.087 0.006 DBMET02482 0.212 0.003 DBMET02483 0.169 0.004 DBMET02484 0.169 0.004 DBMET02485 0.086 0.006 DBMET03697 | DBMET02483 | |
| 0.167 | 0.003 | 0.405 | Progesterone agonist | 0.217 0.002 DBMET02481 0.405 0.001 DBMET02482 0.184 0.002 DBMET02483 0.139 0.003 DBMET02484 0.139 0.003 DBMET02485 0.146 0.003 DBMET03697 | DBMET02482 | |
| 0.271 | 0.11 | 0.619 | Cholesterol antagonist | 0.467 0.038 DBMET02481 0.619 0.016 DBMET02482 0.295 0.094 DBMET02483 0.483 0.035 DBMET02484 0.483 0.035 DBMET02485 0.318 0.08 DBMET03697 | DBMET02482 | |
| 0.17 | 0.01 | 0.226 | Anabolic | 0.188 0.005 DBMET02481 0.226 0.002 DBMET02482 0.174 0.008 DBMET02483 0.188 0.005 DBMET02484 0.188 0.005 DBMET02485 0.183 0.006 DBMET03697 | DBMET02482 | |
| 0.215 | 0.057 | 0.215 | Hepatoprotectant | 0.182 0.078 DBMET02481 0.206 0.061 DBMET02482 0.175 0.085 DBMET02483 0.203 0.063 DBMET02484 0.203 0.063 DBMET02485 0.194 0.069 DBMET03697 | ||
| 0.265 | 0.113 | 0.448 | Apoptosis antagonist | 0.293 0.09 DBMET02481 0.448 0.028 DBMET02482 0.305 0.082 DBMET02483 0.351 0.055 DBMET02484 0.351 0.055 DBMET02485 0.365 0.049 DBMET03697 | DBMET02482 | |
| 0.174 | 0.032 | 0.174 | Farnesoid X receptor antagonist | 0.125 0.092 DBMET02481 0.153 0.049 DBMET02482 0.122 0.1 DBMET02483 0.117 0.111 DBMET03697 | ||
| 0.185 | 0.049 | 0.364 | Melanin inhibitor | 0.201 0.04 DBMET02481 0.364 0.015 DBMET02482 0.197 0.042 DBMET02483 0.179 0.052 DBMET02484 0.179 0.052 DBMET02485 0.233 0.031 DBMET03697 | DBMET02482 | |
| 0.171 | 0.039 | 0.222 | DNA polymerase I inhibitor | 0.17 0.039 DBMET02481 0.222 0.022 DBMET02482 0.194 0.03 DBMET02483 0.214 0.024 DBMET02484 0.214 0.024 DBMET02485 0.198 0.029 DBMET03697 | DBMET02482 | |
| 0.209 | 0.088 | 0.354 | Hypolipemic | 0.267 0.06 DBMET02482 0.178 0.111 DBMET02483 0.354 0.034 DBMET02484 0.354 0.034 DBMET02485 0.186 0.105 DBMET03697 | DBMET02485 | |
| 0.128 | 0.012 | 0.145 | Na+ K+ transporting ATPase inhibitor | 0.13 0.012 DBMET02481 0.142 0.007 DBMET02482 0.132 0.011 DBMET02483 0.145 0.007 DBMET02484 0.145 0.007 DBMET02485 0.139 0.008 DBMET03697 | DBMET02485 | |
| 0.117 | 0.008 | 0.253 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.129 0.006 DBMET02481 0.253 0.003 DBMET02482 0.209 0.004 DBMET02483 0.151 0.005 DBMET02484 0.151 0.005 DBMET02485 0.199 0.004 DBMET03697 | DBMET02482 | |
| 0.11 | 0.004 | 0.495 | 5-Alpha-reductase 1 inhibitor | 0.175 0.003 DBMET02481 0.495 0.001 DBMET02482 0.117 0.004 DBMET02483 0.044 0.007 DBMET03697 | DBMET02482 | |
| 0.109 | 0.005 | 0.109 | Nitric oxide donor | |||
| 0.108 | 0.004 | 0.112 | Lipocortins synthesis agonist | 0.109 0.004 DBMET02481 0.112 0.004 DBMET02482 0.112 0.004 DBMET02483 0.102 0.005 DBMET02484 0.102 0.005 DBMET02485 0.102 0.005 DBMET03697 | DBMET02483 | |
| 0.1 | 0.005 | 0.419 | 5-Alpha-reductase 2 inhibitor | 0.176 0.003 DBMET02481 0.419 0.001 DBMET02482 0.122 0.004 DBMET02483 0.095 0.005 DBMET02484 0.095 0.005 DBMET02485 0.057 0.007 DBMET03697 | DBMET02482 | |
| 0.158 | 0.063 | 0.341 | Protein kinase stimulant | 0.11 0.104 DBMET02481 0.341 0.013 DBMET02482 0.125 0.088 DBMET03697 | DBMET02482 | |
| 0.138 | 0.045 | 0.268 | Microtubule formation inhibitor | 0.15 0.037 DBMET02481 0.227 0.014 DBMET02482 0.242 0.011 DBMET02483 0.268 0.005 DBMET02484 0.268 0.005 DBMET02485 0.259 0.006 DBMET03697 | DBMET02485 | |
| 0.191 | 0.108 | 0.191 | Platelet antagonist | |||
| 0.077 | 0.005 | 0.344 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.093 0.004 DBMET02481 0.344 0.002 DBMET02482 0.145 0.004 DBMET02483 0.068 0.006 DBMET02484 0.068 0.006 DBMET02485 0.119 0.004 DBMET03697 | DBMET02482 | |
| 0.077 | 0.018 | 0.095 | Endothelin-converting enzyme inhibitor | 0.095 0.015 DBMET02481 | DBMET02481 | |
| 0.112 | 0.053 | 0.146 | Toll-Like receptor 4 antagonist | 0.131 0.033 DBMET02481 0.107 0.058 DBMET02482 0.125 0.038 DBMET02483 0.146 0.023 DBMET02484 0.146 0.023 DBMET02485 0.124 0.04 DBMET03697 | DBMET02485 | |
| 0.161 | 0.103 | 0.237 | Non-steroidal antiinflammatory agent | 0.237 0.049 DBMET02482 0.144 0.124 DBMET02483 0.159 0.105 DBMET03697 | DBMET02482 | |
| 0.14 | 0.083 | 0.218 | NOS3 expression enhancer | 0.155 0.067 DBMET02481 0.218 0.034 DBMET02482 0.155 0.067 DBMET02483 0.138 0.087 DBMET03697 | DBMET02482 | |
| 0.073 | 0.018 | 0.073 | Angiotensin-converting enzyme inhibitor | |||
| 0.098 | 0.047 | 0.189 | Antineoplastic antibiotic | 0.095 0.048 DBMET02481 0.165 0.028 DBMET02482 0.114 0.04 DBMET02483 0.189 0.023 DBMET02484 0.189 0.023 DBMET02485 0.136 0.034 DBMET03697 | DBMET02485 | |
| 0.054 | 0.007 | 0.133 | Estrone sulfatase inhibitor | 0.077 0.005 DBMET02481 0.133 0.004 DBMET02482 0.075 0.005 DBMET02483 0.045 0.008 DBMET02484 0.045 0.008 DBMET02485 0.054 0.007 DBMET03697 | DBMET02482 | |
| 0.05 | 0.004 | 0.053 | Glucocorticoid agonist | 0.05 0.004 DBMET02481 0.053 0.004 DBMET02482 0.052 0.004 DBMET02483 0.045 0.005 DBMET02484 0.045 0.005 DBMET02485 0.03 0.006 DBMET03697 | DBMET02482 | |
| 0.07 | 0.025 | 0.087 | Heme oxygenase stimulant | 0.074 0.021 DBMET02481 0.087 0.011 DBMET02482 0.072 0.023 DBMET02483 0.064 0.035 DBMET02484 0.064 0.035 DBMET02485 0.071 0.024 DBMET03697 | DBMET02482 | |
| 0.052 | 0.01 | 0.06 | Glucose-6-phosphate dehydrogenase inhibitor | 0.054 0.009 DBMET02481 0.06 0.007 DBMET02482 0.058 0.008 DBMET02483 0.055 0.009 DBMET02484 0.055 0.009 DBMET02485 0.054 0.009 DBMET03697 | DBMET02482 | |
| 0.06 | 0.018 | 0.06 | Opioid kappa receptor agonist | 0.042 0.031 DBMET02482 | ||
| 0.045 | 0.004 | 0.046 | Corticosteroid-like | 0.046 0.003 DBMET02481 0.045 0.004 DBMET02482 0.045 0.004 DBMET02483 0.035 0.005 DBMET02484 0.035 0.005 DBMET02485 0.036 0.005 DBMET03697 | DBMET02481 | |
| 0.041 | 0.014 | 0.052 | HMG CoA reductase inhibitor | 0.034 0.025 DBMET02481 0.045 0.01 DBMET02482 0.035 0.023 DBMET02483 0.052 0.006 DBMET02484 0.052 0.006 DBMET02485 0.038 0.017 DBMET03697 | DBMET02485 | |
| 0.052 | 0.026 | 0.072 | Microtubule stabilization | 0.054 0.022 DBMET02481 0.061 0.014 DBMET02482 0.064 0.01 DBMET02483 0.072 0.005 DBMET02484 0.072 0.005 DBMET02485 0.066 0.009 DBMET03697 | DBMET02485 | |
| 0.188 | 0.167 | 0.506 | Hypoxia-inducible factor 1 alpha inhibitor | 0.213 0.137 DBMET02481 0.506 0.014 DBMET02482 0.213 0.137 DBMET02483 0.187 0.168 DBMET03697 | DBMET02482 | |
| 0.038 | 0.018 | 0.049 | Tubulin agonist | 0.038 0.017 DBMET02481 0.048 0.009 DBMET02482 0.042 0.013 DBMET02483 0.049 0.009 DBMET02484 0.049 0.009 DBMET02485 0.049 0.009 DBMET03697 | DBMET03697 | |
| 0.02 | 0.003 | 0.027 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.021 0.003 DBMET02481 0.027 0.002 DBMET02482 0.02 0.003 DBMET02483 0.012 0.01 DBMET02484 0.012 0.01 DBMET02485 0.018 0.003 DBMET03697 | DBMET02482 | |
| 0.161 | 0.152 | 0.216 | Antioxidant | 0.169 0.144 DBMET02481 0.216 0.104 DBMET02482 0.19 0.122 DBMET02484 0.19 0.122 DBMET02485 0.166 0.147 DBMET03697 | DBMET02482 | |
| 0.047 | 0.043 | 0.082 | Protein 50S ribosomal subunit inhibitor | 0.054 0.036 DBMET02481 0.069 0.025 DBMET02482 0.059 0.032 DBMET02483 0.082 0.019 DBMET02484 0.082 0.019 DBMET02485 0.071 0.024 DBMET03697 | DBMET02485 | |
| 0.074 | 0.073 | 0.184 | Antineoplastic alkaloid | 0.085 0.06 DBMET02481 0.184 0.018 DBMET02482 0.079 0.067 DBMET02483 0.09 0.054 DBMET02484 0.09 0.054 DBMET02485 0.111 0.041 DBMET03697 | DBMET02482 | |
| 0.003 | 0.008 | 0.007 | Transcortin receptor antagonist | 0.007 0.003 DBMET02482 | DBMET02482 | |
| 0.05 | 0.064 | 0.072 | Pregnane X receptor antagonist | 0.072 0.012 DBMET02482 | DBMET02482 | |
| 0.067 | 0.082 | 0.137 | Glycine receptor antagonist | 0.079 0.058 DBMET02481 0.137 0.011 DBMET02482 0.105 0.028 DBMET02483 0.132 0.012 DBMET02484 0.132 0.012 DBMET02485 0.114 0.021 DBMET03697 | DBMET02482 | |
| 0.15 | 0.172 | 0.444 | DNA damaging | 0.444 0.02 DBMET02482 | DBMET02482 | |
| 0.247 | 0.27 | 0.616 | Antiinflammatory | 0.616 0.049 DBMET02482 0.428 0.122 DBMET02483 0.502 0.087 DBMET02484 0.502 0.087 DBMET02485 0.437 0.117 DBMET03697 | DBMET02482 | |
| 0.004 | 0.032 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 DBMET02482 | DBMET02482 | |
| 0.009 | 0.039 | 0.143 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.143 0.004 DBMET02482 0.023 0.012 DBMET02483 0.034 0.008 DBMET02484 0.034 0.008 DBMET02485 0.021 0.013 DBMET03697 | DBMET02482 | |
| 0.01 | 0.048 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET02482 0.016 0.013 DBMET02484 0.016 0.013 DBMET02485 | DBMET02482 | |
| 0.011 | 0.07 | 0.091 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.091 0.005 DBMET02482 | DBMET02482 | |
| 0.12 | 0.19 | 0.267 | Neurotrophic factor enhancer | 0.146 0.144 DBMET02481 0.267 0.03 DBMET02482 0.159 0.124 DBMET02483 0.153 0.134 DBMET02484 0.153 0.134 DBMET02485 0.192 0.085 DBMET03697 | DBMET02482 | |
| 0.077 | 0.157 | 0.117 | Lipid peroxidase inhibitor | 0.117 0.097 DBMET02482 | DBMET02482 | |
| 0.044 | 0.14 | 0.076 | CDC25A inhibitor | 0.076 0.048 DBMET02482 | DBMET02482 | |
| 0.043 | 0.142 | 0.085 | Ornithine decarboxylase inhibitor | 0.085 0.062 DBMET02482 | DBMET02482 | |
| 0.046 | 0.149 | 0.087 | Glycine receptor agonist | 0.087 0.031 DBMET02482 0.084 0.034 DBMET02484 0.084 0.034 DBMET02485 | DBMET02482 | |
| 0.019 | 0.13 | 0.041 | Liver X receptor agonist | 0.041 0.034 DBMET02482 0.041 0.034 DBMET02484 0.041 0.034 DBMET02485 | DBMET02485 | |
| 0.015 | 0.134 | 0.091 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.091 0.013 DBMET02482 | DBMET02482 | |
| 0.016 | 0.15 | 0.035 | Hedgehog signaling activator | 0.035 0.006 DBMET02484 0.035 0.006 DBMET02485 | DBMET02485 | |
| 0.071 | 0.205 | 0.268 | Angiogenesis stimulant | 0.137 0.131 DBMET02482 0.268 0.062 DBMET02484 0.268 0.062 DBMET02485 0.161 0.116 DBMET03697 | DBMET02485 | |
| 0.094 | 0.232 | 0.251 | Immunostimulant | 0.197 0.122 DBMET02481 0.191 0.126 DBMET02482 0.251 0.096 DBMET02484 0.251 0.096 DBMET02485 0.157 0.149 DBMET03697 | DBMET02485 | |
| 0.151 | 0.298 | 0.397 | Antibacterial | 0.218 0.209 DBMET02481 0.296 0.139 DBMET02482 0.26 0.167 DBMET02483 0.397 0.078 DBMET02484 0.397 0.078 DBMET02485 0.356 0.099 DBMET03697 | DBMET02485 | |
| 0.041 | 0.196 | 0.07 | Keratolytic | 0.07 0.065 DBMET02482 | DBMET02482 | |
| 0.052 | 0.213 | 0.106 | ABCA1 expression enhancer | 0.106 0.043 DBMET02482 | DBMET02482 | |
| 0.072 | 0.247 | 0.399 | Anesthetic general | 0.399 0.016 DBMET02482 0.186 0.083 DBMET02483 0.164 0.099 DBMET02484 0.164 0.099 DBMET02485 0.19 0.08 DBMET03697 | DBMET02482 | |
| 0.015 | 0.214 | 0.051 | Liver X receptor alpha agonist | 0.051 0.018 DBMET02482 0.037 0.035 DBMET02484 0.037 0.035 DBMET02485 | DBMET02482 | |
| 0.069 | 0.271 | 0.142 | Interleukin 2 antagonist | 0.142 0.023 DBMET02482 0.099 0.097 DBMET02483 0.113 0.056 DBMET02484 0.113 0.056 DBMET02485 | DBMET02482 | |
| 0.011 | 0.219 | 0.107 | Potassium channel Kv1.3 blocker | 0.107 0.007 DBMET02482 | DBMET02482 | |
| 0.162 | 0.389 | 0.481 | Caspase 9 stimulant | 0.481 0.068 DBMET02482 0.302 0.192 DBMET02483 0.254 0.249 DBMET02484 0.254 0.249 DBMET02485 0.364 0.135 DBMET03697 | DBMET02482 | |
| 0.026 | 0.259 | 0.051 | Vanilloid 2 antagonist | 0.051 0.039 DBMET02481 | DBMET02481 | |
| 0.035 | 0.272 | 0.096 | Opioid kappa receptor antagonist | 0.096 0.039 DBMET02482 | DBMET02482 | |
| 0.039 | 0.278 | 0.09 | Bile acid receptor antagonist | 0.09 0.074 DBMET02482 | DBMET02482 | |
| 0.102 | 0.341 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.132 0.107 DBMET02482 | DBMET02482 | |
| 0.017 | 0.284 | 0.075 | Acetylcholine nicotinic antagonist | 0.075 0.061 DBMET02482 | DBMET02482 | |
| 0.067 | 0.349 | 0.161 | Pregnane X receptor agonist | 0.161 0.036 DBMET02482 | DBMET02482 | |
| 0.121 | 0.421 | 0.216 | 5 Hydroxytryptamine uptake stimulant | 0.216 0.122 DBMET02482 0.191 0.172 DBMET02483 0.186 0.182 DBMET03697 | DBMET02482 | |
| 0.085 | 0.39 | 0.175 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.16 0.126 DBMET02481 0.175 0.1 DBMET02482 0.153 0.143 DBMET03697 | DBMET02482 | |
| 0.057 | 0.386 | 0.127 | Adenylate cyclase stimulant | 0.126 0.11 DBMET02482 0.127 0.108 DBMET02484 0.127 0.108 DBMET02485 | DBMET02485 | |
| 0.077 | 0.412 | 0.241 | Gastrin inhibitor | 0.241 0.09 DBMET02482 | DBMET02482 | |
| 0.008 | 0.355 | 0.055 | HIV-1 integrase (Strand Transfer) inhibitor | 0.055 0.045 DBMET03697 | DBMET03697 | |
| 0.038 | 0.388 | 0.107 | Aldehyde dehydrogenase inhibitor | 0.107 0.087 DBMET02482 | DBMET02482 | |
| 0.044 | 0.414 | 0.195 | Aldehyde oxidase inhibitor | 0.195 0.107 DBMET02482 | DBMET02482 | |
| 0.024 | 0.396 | 0.228 | Psychostimulant | 0.228 0.067 DBMET02482 | DBMET02482 | |
| 0.015 | 0.395 | 0.054 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.047 DBMET02484 0.054 0.047 DBMET02485 | DBMET02485 | |
| 0.003 | 0.406 | 0.026 | Aminopeptidase P inhibitor | 0.026 0.013 DBMET02481 | DBMET02481 | |
| 0.075 | 0.526 | 0.243 | Caspase 3 stimulant | 0.243 0.119 DBMET02482 0.2 0.169 DBMET03697 | DBMET02482 | |
| 0.012 | 0.479 | 0.113 | Alkylator | 0.113 0.074 DBMET02482 | DBMET02482 | |
| 0.037 | 0.514 | 0.165 | Antipruritic | 0.165 0.079 DBMET02482 | DBMET02482 | |
| 0.041 | 0.573 | 0.139 | Sigma receptor agonist | 0.139 0.094 DBMET02482 | DBMET02482 | |
| 0.019 | 0.592 | 0.142 | Antimitotic | 0.142 0.129 DBMET02484 0.142 0.129 DBMET02485 | DBMET02485 | |
| 0.029 | 0.651 | 0.288 | Antiobesity | 0.206 0.202 DBMET02483 0.24 0.166 DBMET02484 0.24 0.166 DBMET02485 0.288 0.124 DBMET03697 | DBMET03697 | |
| 0.011 | 0.698 | 0.083 | Elastase 1 inhibitor | 0.083 0.033 DBMET02483 0.069 0.049 DBMET02484 0.069 0.049 DBMET02485 0.073 0.043 DBMET03697 | DBMET02483 | |
| 0.051 | 0.899 | 0.264 | Peptidyltransferase inhibitor | 0.264 0.042 DBMET02484 0.264 0.042 DBMET02485 | DBMET02485 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |